We observed similar immunogenic responses as we were developing a syngeneic mouse model bearing CT26 colon cancer cells to evaluate immune checkpoint inhibitor therapies using rat-derived anti-mouse PD-L1 antibodies. Here, CD274 is linked to colonic neoplasm.